TP53 and glioblastoma: IDH-wild-type glioblastomas comprise over 90% of glioblastomas and show TERT promoter mutations, CDKN2A/B homozygous loss, EGFR amplification, TP53 and PTEN mutations, as most frequent common and mostly concurrent alterations [2].